• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Advantages and limits of ADAMTS13 testing in thrombotic thrombocytopenic purpura.

作者信息

Franchini Massimo, Mannucci Pier Mannuccio

机构信息

Servizio di Immunoematologia e Trasfusione, Azienda Ospedaliera di Verona, Italy.

出版信息

Blood Transfus. 2008 Jul;6(3):127-35. doi: 10.2450/2008.0056-07.

DOI:10.2450/2008.0056-07
PMID:18705236
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC2626866/
Abstract
摘要

相似文献

1
Advantages and limits of ADAMTS13 testing in thrombotic thrombocytopenic purpura.血栓性血小板减少性紫癜中ADAMTS13检测的优势与局限
Blood Transfus. 2008 Jul;6(3):127-35. doi: 10.2450/2008.0056-07.
2
[Thrombotic Thrombocytopenic Purpura --Pathophysiology and Assays of ADAMTS13 Activity].[血栓性血小板减少性紫癜——ADAMTS13活性的病理生理学及检测]
Rinsho Byori. 2015 Oct;63(10):1228-36.
3
ADAMTS-13 assays in thrombotic thrombocytopenic purpura.ADAMTS-13 检测在血栓性血小板减少性紫癜中的应用。
J Thromb Haemost. 2010 Apr;8(4):631-40. doi: 10.1111/j.1538-7836.2010.03761.x. Epub 2010 Jan 21.
4
Congenital ADAMTS13 deficiency: a rare mimicker of immune thrombocytopenic purpura.先天性ADAMTS13缺乏症：一种罕见的免疫性血小板减少性紫癜模仿者。
J Pediatr Hematol Oncol. 2014 Nov;36(8):653-5. doi: 10.1097/MPH.0000000000000180.
5
Thrombotic thrombocytopenic purpura: a moving target.血栓性血小板减少性紫癜：一个不断变化的目标。
Hematology Am Soc Hematol Educ Program. 2006:415-20. doi: 10.1182/asheducation-2006.1.415.
6
Thrombotic thrombocytopenic purpura and its diagnosis.
J Thromb Haemost. 2005 Nov;3(11):2420-7. doi: 10.1111/j.1538-7836.2005.01350.x. Epub 2005 May 9.
7
Thrombotic thrombocytopenic purpura: a thrombotic disorder caused by ADAMTS13 deficiency.血栓性血小板减少性紫癜：一种由ADAMTS13缺乏引起的血栓性疾病。
Hematol Oncol Clin North Am. 2007 Aug;21(4):609-32, v. doi: 10.1016/j.hoc.2007.06.003.
8
Anti-ADAMTS13 IgG autoantibodies present in healthy individuals share linear epitopes with those in patients with thrombotic thrombocytopenic purpura.健康个体中存在的抗ADAMTS13 IgG自身抗体与血栓性血小板减少性紫癜患者的自身抗体具有相同的线性表位。
Haematologica. 2014 Apr;99(4):e58-60. doi: 10.3324/haematol.2013.100685. Epub 2014 Feb 14.
9
Advantages and limits of ADAMTS13 testing in the prognostic assessment of thrombotic thrombocytopenic purpura.ADAMTS13检测在血栓性血小板减少性紫癜预后评估中的优势与局限
Presse Med. 2012 Mar;41(3 Pt 2):e157-62. doi: 10.1016/j.lpm.2011.10.025. Epub 2012 Jan 13.
10
[Hemolytic uremic syndrome and thrombotic thrombocytopenic purpura. Current perspectives on EHEC, complement mutations and ADAMTS13].[溶血尿毒综合征和血栓性血小板减少性紫癜。关于肠出血性大肠杆菌、补体突变及含血小板解聚蛋白基金属蛋白酶13的当前观点]
Lakartidningen. 2008;105(15):1096-101.

引用本文的文献

1
von Willebrand factor, ADAMTS-13, and thrombospondin 1 in relation to clinical outcomes in elderly patients with a recent myocardial infarction.血管性血友病因子、含血小板解聚蛋白基元的金属蛋白酶13及血小板反应蛋白1与近期发生心肌梗死的老年患者临床结局的关系
Res Pract Thromb Haemost. 2023 Apr 23;7(4):100164. doi: 10.1016/j.rpth.2023.100164. eCollection 2023 May.
2
A Case of Thrombotic Thrombocytopenic Purpura Possibly Induced by Graves' Disease.1例可能由格雷夫斯病诱发的血栓性血小板减少性紫癜病例。
Cureus. 2022 Oct 5;14(10):e29961. doi: 10.7759/cureus.29961. eCollection 2022 Oct.
3
An Imperfect Marker: SLE and TTP-Like MAHA Without Low ADAMTS13.不典型标志物：SLE 与 TTP 样 MAHA 而 ADAMTS13 正常
J Investig Med High Impact Case Rep. 2021 Jan-Dec;9:23247096211029746. doi: 10.1177/23247096211029746.
4
Reference range for ADAMTS13 antigen, activity and anti-ADAMTS13 antibody in the healthy adult Singapore population.健康新加坡成年人 ADAMTS13 抗原、活性和抗 ADAMTS13 抗体的参考范围。
Singapore Med J. 2022 Apr;63(4):214-218. doi: 10.11622/smedj.2020093. Epub 2020 Jun 26.
5
Utilizing a PLASMIC score-based approach in the management of suspected immune thrombotic thrombocytopenic purpura: a cost minimization analysis within the Harvard TMA Research Collaborative.基于 PLASMIC 评分的方法在疑似免疫性血栓性血小板减少性紫癜管理中的应用：哈佛 TMA 研究协作中的成本最小化分析。
Br J Haematol. 2019 Aug;186(3):490-498. doi: 10.1111/bjh.15932. Epub 2019 May 26.
6
Gemcitabine-induced haemolytic uraemic syndrome in pancreatic adenocarcinoma.吉西他滨诱导的胰腺腺癌溶血性尿毒症综合征
BMJ Case Rep. 2019 Apr 8;12(4):e228363. doi: 10.1136/bcr-2018-228363.
7
Thrombotic thrombocytopenic purpura possibly triggered by Graves' disease.可能由格雷夫斯病引发的血栓性血小板减少性紫癜。
Oxf Med Case Reports. 2017 Oct 24;2017(10):omx057. doi: 10.1093/omcr/omx057. eCollection 2017 Oct.
8
Thrombotic Thrombocytopenic Purpura in Black People: Impact of Ethnicity on Survival and Genetic Risk Factors.黑人中的血栓性血小板减少性紫癜：种族对生存及遗传风险因素的影响
PLoS One. 2016 Jul 6;11(7):e0156679. doi: 10.1371/journal.pone.0156679. eCollection 2016.
9
High frequency of acquired ADAMTS13 deficiency after hemolysis in Hemiscorpius Lepturus (scorpion) stung children.以色列金蝎蜇伤儿童溶血后获得性ADAMTS13缺乏症的高发生率
Indian J Pediatr. 2014 Jul;81(7):665-9. doi: 10.1007/s12098-013-1089-5. Epub 2013 Jul 28.
10
Thrombotic microangiopathies.血栓性微血管病
ISRN Hematol. 2012;2012:310596. doi: 10.5402/2012/310596. Epub 2012 Jul 25.

本文引用的文献

1
ADAMTS13 and anti-ADAMTS13 antibodies as markers for recurrence of acquired thrombotic thrombocytopenic purpura during remission.ADAMTS13和抗ADAMTS13抗体作为获得性血栓性血小板减少性紫癜缓解期复发的标志物。
Haematologica. 2008 Feb;93(2):232-9. doi: 10.3324/haematol.11739. Epub 2008 Jan 26.
2
ADAMTS13 activity to antigen ratio in physiological and pathological conditions associated with an increased risk of thrombosis.在与血栓形成风险增加相关的生理和病理状况下的ADAMTS13活性与抗原比值。
Br J Haematol. 2007 Aug;138(4):534-40. doi: 10.1111/j.1365-2141.2007.06688.x. Epub 2007 Jun 29.
3
Prognostic value of anti-ADAMTS 13 antibody features (Ig isotype, titer, and inhibitory effect) in a cohort of 35 adult French patients undergoing a first episode of thrombotic microangiopathy with undetectable ADAMTS 13 activity.在35名首次发生血栓性微血管病且ADAMTS 13活性检测不到的成年法国患者队列中，抗ADAMTS 13抗体特征（免疫球蛋白同种型、滴度和抑制作用）的预后价值
Blood. 2007 Apr 1;109(7):2815-22. doi: 10.1182/blood-2006-02-006064.
4
Thrombotic microangiopathy with acquired deficiency in ADAMTS 13 activity in lung transplant recipients.肺移植受者中伴有获得性ADAMTS 13活性缺乏的血栓性微血管病。
Transplantation. 2006 Jun 27;81(12):1628-32. doi: 10.1097/01.tp.0000226066.82066.fa.
5
FRETS-VWF73: a rapid and predictive tool for thrombotic thrombocytopenic purpura.荧光共振能量转移-血管性血友病因子73：一种用于血栓性血小板减少性紫癜的快速预测工具。
J Thromb Haemost. 2006 Mar;4(3):698-9. doi: 10.1111/j.1538-7836.2005.01767.x.
6
Current concepts in thrombotic thrombocytopenic purpura.血栓性血小板减少性紫癜的当前概念。
Annu Rev Med. 2006;57:419-36. doi: 10.1146/annurev.med.57.061804.084505.
7
Relapse of thrombotic thrombocytopenic purpura: is it a continuum of disease?
Semin Thromb Hemost. 2005 Dec;31(6):700-8. doi: 10.1055/s-2005-925476.
8
Molecular biology of ADAMTS13 and diagnostic utility of ADAMTS13 proteolytic activity and inhibitor assays.ADAMTS13的分子生物学以及ADAMTS13蛋白水解活性和抑制剂检测的诊断效用
Semin Thromb Hemost. 2005 Dec;31(6):659-72. doi: 10.1055/s-2005-925472.
9
Prognostic value of inhibitory anti-ADAMTS13 antibodies in adult-acquired thrombotic thrombocytopenic purpura.抑制性抗ADAMTS13抗体在成人获得性血栓性血小板减少性紫癜中的预后价值。
Br J Haematol. 2006 Jan;132(1):66-74. doi: 10.1111/j.1365-2141.2005.05837.x.
10
Measurement of ADAMTS13 activity and inhibitors.ADAMTS13活性及抑制剂的测定。
Curr Opin Hematol. 2005 Sep;12(5):384-9. doi: 10.1097/01.moh.0000169286.74464.3a.